These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23710969)
21. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors. Ravichandran V; Shalini S; Sundram K; Sokkalingam AD Eur J Med Chem; 2010 Jul; 45(7):2791-7. PubMed ID: 20347187 [TBL] [Abstract][Full Text] [Related]
22. Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK. Tanis SP; Plewe MB; Johnson TW; Butler SL; Dalvie D; DeLisle D; Dress KR; Hu Q; Huang B; Kuehler JE; Kuki A; Liu W; Peng Q; Smith GL; Solowiej J; Tran KT; Wang H; Yang A; Yin C; Yu X; Zhang J; Zhu H Bioorg Med Chem Lett; 2010 Dec; 20(24):7429-34. PubMed ID: 21036042 [TBL] [Abstract][Full Text] [Related]
23. Discovery of HIV-1 integrase inhibitors by pharmacophore searching. Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481 [TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179 [TBL] [Abstract][Full Text] [Related]
25. QSAR studies of HIV-1 integrase inhibition. Yuan H; Parrill AL Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870 [TBL] [Abstract][Full Text] [Related]
26. Efficient 3D database screening for novel HIV-1 IN inhibitors. Barreca ML; Rao A; De Luca L; ZappalĂ M; Gurnari C; Monforte P; De Clercq E; Van Maele B; Debyser Z; Witvrouw M; Briggs JM; Chimirri A J Chem Inf Comput Sci; 2004; 44(4):1450-5. PubMed ID: 15272853 [TBL] [Abstract][Full Text] [Related]
27. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors. Bhatt HG; Patel PK Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667 [TBL] [Abstract][Full Text] [Related]
28. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach. Parenti MD; Pacchioni S; Ferrari AM; Rastelli G J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997 [TBL] [Abstract][Full Text] [Related]
29. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. Deng J; Lee KW; Sanchez T; Cui M; Neamati N; Briggs JM J Med Chem; 2005 Mar; 48(5):1496-505. PubMed ID: 15743192 [TBL] [Abstract][Full Text] [Related]
30. Development of pharmacophore similarity-based quantitative activity hypothesis and its applicability domain: applied on a diverse data-set of HIV-1 integrase inhibitors. Kumar SP; Jasrai YT; Mehta VP; Pandya HA J Biomol Struct Dyn; 2015; 33(4):706-22. PubMed ID: 24735019 [TBL] [Abstract][Full Text] [Related]
31. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds]. Yu SH; Tan YM; Zhao GS Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431 [TBL] [Abstract][Full Text] [Related]
32. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598 [TBL] [Abstract][Full Text] [Related]
33. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Leonard JT; Roy K Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064 [TBL] [Abstract][Full Text] [Related]
34. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684 [TBL] [Abstract][Full Text] [Related]
35. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints. Iyer M; Hopfinger AJ J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors. Li X; Vince R Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300 [TBL] [Abstract][Full Text] [Related]
37. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors. Gupta P; Roy N; Garg P Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906 [TBL] [Abstract][Full Text] [Related]
38. Diverse models for the prediction of HIV integrase inhibitory activity of substituted quinolone carboxylic acids. Gupta M; Madan AK Arch Pharm (Weinheim); 2012 Dec; 345(12):989-1000. PubMed ID: 22945879 [TBL] [Abstract][Full Text] [Related]
39. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors. Cheng Z; Zhang Y; Fu W Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721 [TBL] [Abstract][Full Text] [Related]
40. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase. Wang Z; Tang J; Salomon CE; Dreis CD; Vince R Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]